Adagio Therapeutics
met the trial primary objective with relative risk of hospitalization or death reduced by compared to placebo among non omicron population | Adagio Therapeutics
Deck Type
Deck date
June 2022
Slide
3 of 4
Other recent decks by Adagio Therapeutics
Results
November 2023
Investor Presentation
June 2023
Investor Conference
June 2023
Investor Presentation
May 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io